Literature DB >> 22422287

Sequence analysis of 5' regulatory regions of the Machado-Joseph disease gene (ATXN3).

Conceição Bettencourt1, Mafalda Raposo, Nadiya Kazachkova, Cristina Santos, Teresa Kay, João Vasconcelos, Patrícia Maciel, Karina C Donis, Maria Luiza Saraiva-Pereira, Laura B Jardim, Jorge Sequeiros, Jácome Bruges-Armas, Manuela Lima.   

Abstract

Machado-Joseph disease (MJD) is a late-onset autosomal dominant neurodegenerative disorder, which is caused by a coding (CAG)(n) expansion in the ATXN3 gene (14q32.1). The number of CAG repeats in the expanded alleles accounts only for 50 to 75 % of onset variance, the remaining variation being dependent on other factors. Differential allelic expression of ATXN3 could contribute to the explanation of different ages at onset in patients displaying similar CAG repeat sizes. Variation in 5' regulatory regions of the ATXN3 gene may have the potential to influence expression levels and, ultimately, modulate the MJD phenotype. The main goal of this work was to analyze the extent of sequence variation upstream of the ATXN3 start codon. A fragment containing the core promoter and the 5' untranslated region (UTR) was sequenced and analyzed in 186 patients and 59 controls (490 chromosomes). In the core promoter, no polymorphisms were observed. In the 5' UTR, only one SNP (rs3814834) was found, but no improvements on the explanation of onset variance were observed, when adding its allelic state in a linear model. Accordingly, in silico analysis predicted that this SNP lays in a nonconserved position for CMYB binding. Therefore, no functional effect could be predicted for this variant.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22422287     DOI: 10.1007/s12311-012-0373-7

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  26 in total

1.  Genetic variability in the regulatory region of presenilin 1 associated with risk for Alzheimer's disease and variable expression.

Authors:  J Theuns; J Del-Favero; B Dermaut; C M van Duijn; H Backhovens; M V Van den Broeck; S Serneels; E Corsmit; C V Van Broeckhoven; M Cruts
Journal:  Hum Mol Genet       Date:  2000-02-12       Impact factor: 6.150

Review 2.  Role of 5'- and 3'-untranslated regions of mRNAs in human diseases.

Authors:  Sangeeta Chatterjee; Jayanta K Pal
Journal:  Biol Cell       Date:  2009-05       Impact factor: 4.458

3.  The genomic structure and expression of MJD, the Machado-Joseph disease gene.

Authors:  Y Ichikawa; J Goto; M Hattori; A Toyoda; K Ishii; S Y Jeong; H Hashida; N Masuda; K Ogata; F Kasai; M Hirai; P Maciel; G A Rouleau; Y Sakaki; I Kanazawa
Journal:  J Hum Genet       Date:  2001       Impact factor: 3.172

4.  Analysis of the 5' upstream sequence of the Huntington's disease (HD) gene shows six new rare alleles which are unrelated to the age at onset of HD.

Authors:  R Coles; J Leggo; D C Rubinsztein
Journal:  J Med Genet       Date:  1997-05       Impact factor: 6.318

5.  Improvement in the molecular diagnosis of Machado-Joseph disease.

Authors:  P Maciel; M C Costa; A Ferro; M Rousseau; C S Santos; C Gaspar; J Barros; G A Rouleau; P Coutinho; J Sequeiros
Journal:  Arch Neurol       Date:  2001-11

6.  Machado-Joseph disease: correlation between the clinical features, the CAG repeat length and homozygosity for the mutation.

Authors:  I Lerer; D Merims; D Abeliovich; J Zlotogora; N Gadoth
Journal:  Eur J Hum Genet       Date:  1996       Impact factor: 4.246

7.  CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1.

Authors:  Y Kawaguchi; T Okamoto; M Taniwaki; M Aizawa; M Inoue; S Katayama; H Kawakami; S Nakamura; M Nishimura; I Akiguchi
Journal:  Nat Genet       Date:  1994-11       Impact factor: 38.330

8.  Segregation distortion of wild-type alleles at the Machado-Joseph disease locus: a study in normal families from the Azores islands (Portugal).

Authors:  Conceição Bettencourt; Raquel Nunes Fialho; Cristina Santos; Rafael Montiel; Jácome Bruges-Armas; Patrícia Maciel; Manuela Lima
Journal:  J Hum Genet       Date:  2008-02-20       Impact factor: 3.172

9.  The (CAG)n tract of Machado-Joseph Disease gene (ATXN3): a comparison between DNA and mRNA in patients and controls.

Authors:  Conceição Bettencourt; Cristina Santos; Rafael Montiel; Teresa Kay; João Vasconcelos; Patrícia Maciel; Manuela Lima
Journal:  Eur J Hum Genet       Date:  2009-11-25       Impact factor: 4.246

10.  Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.

Authors:  Nancy S Wexler; Judith Lorimer; Julie Porter; Fidela Gomez; Carol Moskowitz; Edith Shackell; Karen Marder; Graciela Penchaszadeh; Simone A Roberts; Javier Gayán; Denise Brocklebank; Stacey S Cherny; Lon R Cardon; Jacqueline Gray; Stephen R Dlouhy; Sandra Wiktorski; Marion E Hodes; P Michael Conneally; Jack B Penney; James Gusella; Jang-Ho Cha; Michael Irizarry; Diana Rosas; Steven Hersch; Zane Hollingsworth; Marcy MacDonald; Anne B Young; J Michael Andresen; David E Housman; Margot Mieja De Young; Ernesto Bonilla; Theresa Stillings; Americo Negrette; S Robert Snodgrass; Maria Dolores Martinez-Jaurrieta; Maria A Ramos-Arroyo; Jacqueline Bickham; Juan Sanchez Ramos; Frederick Marshall; Ira Shoulson; Gustavo J Rey; Andrew Feigin; Norman Arnheim; Amarilis Acevedo-Cruz; Leticia Acosta; Jose Alvir; Kenneth Fischbeck; Leslie M Thompson; Angela Young; Leon Dure; Christopher J O'Brien; Jane Paulsen; Adam Brickman; Denise Krch; Shelley Peery; Penelope Hogarth; Donald S Higgins; Bernhard Landwehrmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-01       Impact factor: 11.205

View more
  3 in total

1.  Transcript diversity of Machado-Joseph disease gene (ATXN3) is not directly determined by SNPs in exonic or flanking intronic regions.

Authors:  Conceição Bettencourt; Mafalda Raposo; Raquel Ros; Rafael Montiel; Jácome Bruges-Armas; Manuela Lima
Journal:  J Mol Neurosci       Date:  2012-06-16       Impact factor: 3.444

2.  Variation in DNA Repair System Gene as an Additional Modifier of Age at Onset in Spinocerebellar Ataxia Type 3/Machado-Joseph Disease.

Authors:  Rafaella Mergener; Gabriel Vasata Furtado; Eduardo Preusser de Mattos; Vanessa Bielefeldt Leotti; Laura Bannach Jardim; Maria Luiza Saraiva-Pereira
Journal:  Neuromolecular Med       Date:  2019-10-05       Impact factor: 3.843

3.  Two novel SNPs in ATXN3 3' UTR may decrease age at onset of SCA3/MJD in Chinese patients.

Authors:  Zhe Long; Zhao Chen; Chunrong Wang; Fengzhen Huang; Huirong Peng; Xuan Hou; Dongxue Ding; Wei Ye; Junling Wang; Qian Pan; Jiada Li; Kun Xia; Beisha Tang; Tetsuo Ashizawa; Hong Jiang
Journal:  PLoS One       Date:  2015-02-17       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.